Universal Ibogaine Inc.
IBOGF · OTC
4/30/2025 | 1/31/2025 | 4/30/2023 | 1/31/2023 | |
|---|---|---|---|---|
| Market Cap | $9,282 | $8,963 | $2,856 | $3,745 |
| - Cash | $128 | $274 | $353 | $192 |
| + Debt | $2,571 | $2,599 | $2,652 | $2,281 |
| Enterprise Value | $11,726 | $11,288 | $5,155 | $5,834 |
| Revenue | $701 | $372 | $428 | $41 |
| % Growth | 88.6% | -13.2% | 937.9% | – |
| Gross Profit | $701 | $11 | $428 | $41 |
| % Margin | 100% | 3.1% | 100% | 100% |
| EBITDA | $53 | -$166 | -$347 | -$737 |
| % Margin | 7.5% | -44.6% | -80.9% | -1,784.8% |
| Net Income | -$66 | -$304 | -$487 | -$793 |
| % Margin | -9.4% | -81.9% | -113.6% | -1,921.3% |
| EPS Diluted | -0 | -0.001 | -0.003 | -0.004 |
| % Growth | 80% | 60% | 39% | – |
| Operating Cash Flow | -$110 | -$202 | -$172 | -$481 |
| Capital Expenditures | $0 | $0 | -$43 | -$211 |
| Free Cash Flow | -$110 | -$202 | -$215 | -$691 |